MADISON, N.J., Aug. 18, 2016 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic services, announced today that the U.S. Department of Health and Human Services (HHS) has authorized the company to perform drug testing using electronic Custody and Control Forms (eCCF) for federally-mandated, safety-sensitive workers. With the approval, Quest becomes the largest workplace drug testing provider certified to provide Federal eCCF, which can enhance efficiencies and improve the quality of the drug testing process, including collection and transport, by significantly reducing paper-based documentation.
The company is now certified to utilize eCCF for all urine workplace drug tests, following the successful completion by four of its workplace drug testing laboratories of the HHS National Laboratory Certification Program (NLCP) inspection and certification process, which involves demonstrating proficiency in several areas, including data security and confidentiality. The labs are located in Lenexa, KS; Tucker, GA; West Hills, CA; and West Norriton, PA. Quest Diagnostics plans to make federal eCCF broadly available to its clients in the fourth quarter.
Quest Diagnostics has provided eCCF to private, non-regulated employers for nearly a decade. Our The network is equipped with barcode scanners, electronic signature pads and other technologies enabling eCCF in 1,300 patient service centers and more than 1,000 preferred drug testing collection sites across the United States.
"Our eCCF certification positions us to comply with regulated drug testing requirements for workers in safety-sensitive roles, particularly workforces mandated by the U.S. Department of Transportation (DOT), to greatly improve the efficiency and quality of documentation for workplace drug testing," said Bob McCormick, Vice President, Quest Diagnostics Employer Solutions. "For years, we've successfully utilized eCCF to provide testing for millions of non-regulated specimens and we look forward to extending this capability to support federal drug-free workplace programs."
eCCF is the electronic version of the traditional, five-part, paper Custody and Control Form – the document used for drug test ordering, specimen collection processing and chain of custody documentation for workplace drug testing. Chain of custody refers to the handling of a drug test specimen from the time it is collected until it is processed at the laboratory – and, in the Federal program, it is also used to document final laboratory results reported to Medical Review Officers (MROs). The DOT published a Final Rule allowing employers, collectors, laboratories and MROs to use Federal eCCF in 2015. Only laboratories that are approved by the NLCP can provide Federal eCCF.
About Quest Diagnostics Employer Solutions
Quest Diagnostics Employer Solutions helps private employers and federally-regulated organizations to foster safe and healthy drug-free work environments. Using the most advanced technologies, we provide workplace drug testing solutions that can identify a range of illicit and prescription drugs in urine, hair and oral fluid specimen types as part of pre-employment, routine and other forms of job screening. The company's Drug Testing Index™ analyzes trends in workplace drug test data and is regarded as a barometer of national workforce drug use trends. For more information, visit www.EmployerSolutions.com or www.QuestDiagnostics.com/DTI.
About Quest Diagnostics
Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our 44,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives. www.QuestDiagnostics.com.
Quest, Quest Diagnostics, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks are the property of their respective owners.
Wendy Bost, Quest Diagnostics (Media): 973-520-2800
Shawn Bevec, Quest Diagnostics (Investors): 973-520-2900
SOURCE Quest Diagnostics